Glattpark
Switzerland
10
2021-01-28
10
2021-08-03
These are the the leading inventors for applications assigned to BAXALTA GMBH:
BAXALTA GMBH based in Glattpark, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Method and apparatus for providing a pharmacokinetic drug dosing regimen
#2 | 2020-12-03 ✅ Patent 11,564,979 granted on 2023-01-31Stabilized liquid and lyophilized ADAMTS13 formulations
#3 | 2020-07-02 ✅ Patent 10,905,746 granted on 2021-02-02Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF
#4 | 2020-03-12 ✅ Patent 11,020,459 granted on 2021-06-01Factor VIII formulations
#5 | 2019-12-19 ✅ Patent 10,934,340 granted on 2021-03-02Separation of VWF and VWF propeptide by chromatographic methods
#6 | 2019-08-15 ✅ Patent 10,758,599 granted on 2020-09-01Stabilized liquid and lyophilized ADAMTS13 formulations
#7 | 2019-06-06 ✅ Patent 10,875,906 granted on 2020-12-29Removal of serine proteases by treatment with finely divided silicon dioxide
#8 | 2019-05-16 ✅ Patent 10,900,979 granted on 2021-01-26Methods for testing effectiveness of a von Willebrand factor used in treating von Willebrand disease (VWD)
#9 | 2018-10-18 ✅ Patent 11,305,000 granted on 2022-04-19Chimeric OspA genes, proteins and methods of use thereof
#10 | 2014-02-20 ✅ Patent 9,417,251 granted on 2016-08-16Methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides
Also check out BAXALTA GMBH's (Glattpark, Switzerland) applicant profile with 15 patent applications submitted.
165964 ⎘